Bohai Pharmaceuticals Group, Inc.: 10-Q filed 2014-05-15
What Bohai Pharmaceuticals Group, Inc. reported in its quarterly report filed 2014-05-15 (fiscal Q3 2014): 44 published measures, 128 facts as tagged in accession 0001511164-14-000263.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-05-15
- Fiscal period
- fiscal Q3 2014
- Accession
- 0001511164-14-000263 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Bohai Pharmaceuticals Group, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 175,707,773 | USD | |
| At 2013-06-30 | 165,624,398 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 49,215,596 | USD | |
| At 2013-06-30 | 57,234,844 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 126,492,177 | USD | |
| At 2013-06-30 | 108,389,554 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 11,265,031 | USD | |
| At 2013-06-30 | 6,947,972 | USD | |
| At 2013-03-31 | 3,755,600 | USD | |
| At 2012-06-30 | 18,386,288 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 3,928,011 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 18,024,773 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 3,159,206 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 14,813,455 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | 12,818,868 | USD | 274 |
| 2012-07-01 to 2013-03-31 | 7,873,829 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | -195,192 | USD | 274 |
| 2012-07-01 to 2013-03-31 | -781,176 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 39,722,126 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 129,284,445 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 34,786,624 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 111,067,950 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | 4,044,717 | USD | 274 |
| 2012-07-01 to 2013-03-31 | -507,329 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | -12,310,177 | USD | 274 |
| 2012-07-01 to 2013-03-31 | -22,131,301 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 92,781,532 | USD | |
| At 2013-06-30 | 74,756,759 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 17,861,085 | shares | 90 |
| 2013-07-01 to 2014-03-31 | 17,861,085 | shares | 274 |
| 2013-01-01 to 2013-03-31 | 17,861,085 | shares | 90 |
| 2012-07-01 to 2013-03-31 | 17,861,085 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 21,831,328 | shares | 90 |
| 2013-07-01 to 2014-03-31 | 21,957,639 | shares | 274 |
| 2013-01-01 to 2013-03-31 | 22,093,335 | shares | 90 |
| 2012-07-01 to 2013-03-31 | 22,093,335 | shares | 274 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 0.22 | USD/shares | 90 |
| 2013-07-01 to 2014-03-31 | 1.01 | USD/shares | 274 |
| 2013-01-01 to 2013-03-31 | 0.18 | USD/shares | 90 |
| 2012-07-01 to 2013-03-31 | 0.83 | USD/shares | 274 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 0.19 | USD/shares | 90 |
| 2013-07-01 to 2014-03-31 | 0.85 | USD/shares | 274 |
| 2013-01-01 to 2013-03-31 | 0.15 | USD/shares | 90 |
| 2012-07-01 to 2013-03-31 | 0.71 | USD/shares | 274 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -1,509,391 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -6,368,930 | USD | 274 |
| 2013-01-01 to 2013-03-31 | -1,036,881 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -4,976,705 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 17,327,863 | USD | |
| At 2013-06-30 | 17,678,453 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 5,770,780 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 25,902,589 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 4,650,363 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 19,962,821 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 75,816,040 | USD | |
| At 2013-06-30 | 62,027,145 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -336,645 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -1,555,573 | USD | 274 |
| 2013-01-01 to 2013-03-31 | -456,930 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -1,396,286 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 33,675,118 | USD | |
| At 2013-06-30 | 35,722,231 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 5,216,982 | USD | |
| At 2013-06-30 | 5,202,209 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 37,350,012 | USD | |
| At 2013-06-30 | 37,863,464 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 23,825,941 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 72,502,702 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 21,216,595 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 64,006,925 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 4,504,744 | USD | |
| At 2013-06-30 | 2,781,734 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 29,596,721 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 98,405,291 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 25,866,958 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 83,969,746 | USD | 274 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 10,125,405 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 30,879,154 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 8,919,666 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 27,098,204 | USD | 274 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 23,103,935 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 70,348,334 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 20,476,092 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 60,230,015 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 25,699 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 88,450 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 1,995 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 5,985 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 17,861,085 | shares | |
| At 2013-06-30 | 17,861,085 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 9,077,431 | USD | |
| At 2013-06-30 | 8,999,581 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 20,917,215 | USD | |
| At 2013-06-30 | 18,212,322 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | -3,668,064 | USD | |
| At 2013-06-30 | -2,827,442 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 11,805,864 | USD | |
| At 2013-06-30 | 12,185,615 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 939,555 | USD | |
| At 2013-06-30 | 1,007,365 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 5,437,402 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 24,393,703 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 4,196,087 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 19,790,160 | USD | 274 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 2,740,325 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 18,102,623 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 3,817,374 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 15,675,706 | USD | 274 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 3,928,011 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 18,024,773 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 3,159,206 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 14,813,455 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 293,168 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 848,747 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 139,789 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 427,279 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -29 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -31,329 | USD | 274 |
| 2013-01-01 to 2013-03-31 | -142 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -16,733 | USD | 274 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | -149,182 | USD | 274 |
| 2012-07-01 to 2013-03-31 | -331,999 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | -7,704,260 | USD | 274 |
| 2012-07-01 to 2013-03-31 | -11,091,285 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | -1,722,546 | USD | 274 |
| 2012-07-01 to 2013-03-31 | 714,984 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | 41,256 | USD | 274 |
| 2012-07-01 to 2013-03-31 | 941,963 | USD | 274 |
Inspect the source
- Entity
- Bohai Pharmaceuticals Group, Inc. / CIK 0001443242
- Captured
- SEC response SHA-256
231cd66af3d2b49ce2aa3d470fecf13855af56710429934b8f03d791fb54b2d8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001443242.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))